A warning has been issued about the third wave of the pandemic, in which most children are feared to be infected. In view of this, a big step has been taken. The Government of India has approved the testing for the second / third phase of Bharat Biotech’s Covid vaccine for age 2 to 18.
The Subject Expert Committee (SEC) associated with the Corona vaccine recommended that India Biotech should approve the second and third phase clinical trials of covacine, which will be done on children between 2 and 18 years of age. And AIIMS in Patna and Meditrina Institute of Medical Sciences, Nagpur.